Request Covid 19 Impact
Why Choose Us
- 360 Degree Approach
- Growth Consulting
- 24/7 Research Support
- Comprehensive-Level of Customization
- Comprehensive-Level of Customization
- Competitive Intelligence
- Single-Country/ Region Intelligence
- Post-Sale Service Assistance
- Access to Lead Analysts
- Available in PDF, Excel, Word/ PPT
The Auto-Injectors Market report also offers insightful and detailed information regarding the various key players operating in the global auto-injectors market, and their financials, apart from strategies, acquisitions & mergers, and market footprint. The global auto-injectors market has been segmented on the basis of product, design, application, and region.
Auto-Injectors Market Overview:
The Auto-Injectors Market was valued at $53.6 billion in 2021 & is projected to reach $89.5 billion by 2027. It is expected to grow at a 19.1% CAGR between 2021 and 2027.
Auto-injectors are medical devices designed for delivering a fixed dose of particular drug and are intended for self-administration by patients.
Auto-injectors are gradually gaining demand for treating various indications such as anaphylaxis, multiple sclerosis, rheumatoid arthritis, and others. Most auto-injectors are spring-loaded syringes, which make the procedure relatively simple.
These instruments are specially made to avoid needle stick injury, anxiety, blood clots, and needle phobia among patients. The location for injecting a particular drug is dependent on the nature of the drug, however, it is normally taken through any intramuscular route.
Factors driving the growth of the global auto-injectors market include rising incidences of anaphylactic shock, rising awareness of patients about auto-injectors coupled with rising preference for self-administration of injections.
Auto-injectors provide inexpensive home medication and reduce dependency on healthcare professionals and time consumed at in-patient and out-patient care units, thereby fueling the growth of the global auto-injectors market.
In addition, factors such as rising geriatric population and high production of biologics are also contributing to growth of the global auto-injectors market.
Despite various advantages of auto-injectors, high prices of these injectors and availability of substitute products such as general injections and oral tablets may hamper growth of this market in the near future.
North America is largest market for auto-injectors owing to increasing diabetes and anaphylaxis cases, and increasing production of biologics.
The auto-injectors market is expected to witness the fastest growth in the Asia Pacific during the forecast period owing to increasing cases of anaphylaxis, increasing awareness about needle-stick injuries, rising healthcare expenditure, and a growing geriatric population.
Global Auto-Injectors Market Segmentation:
Global auto-injectors market segmentation by product:
Global auto-injectors market segmentation by design:
Global auto-injectors market segmentation by application:
- Multiple Sclerosis
- Rheumatoid Arthritis
Global auto-injectors market segmentation by distribution channels:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Drug Stores
Global auto-injectors market segmentation by region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Attribute Report Details Market Size Ask For Market Size Growth Rate Ask For Growth Rate Key Companies Ask For Companies Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more… Historical Data Period 2015-2020 Base Year 2022 Forecast Period 2022-2031 Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa Revenue in US$ Mn
- Mylan N.V.
- Antares Pharma Inc.
- Becton, Dickinson & Co.
- Eli Lilly and Company
- Pfizer, Inc.
- Bayer AG
- Novartis International AG
- Bristol-Myer Squibb
- Amgen Inc.
- Biogen Inc.
Request for TOC
Don't just take our word. We are trusted by these great companies!